Presentation is loading. Please wait.

Presentation is loading. Please wait.

Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study

Published byHallvard Hagen Modified over 6 years ago

Similar presentations

Presentation on theme: "Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study"— Presentation transcript:

1 Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study
Jun-Jun Yeh, MD, Yu-Chiao Wang, MSc, Wu-Huei Hsu, MD, Chia-Hung Kao, MD  Journal of Allergy and Clinical Immunology  Volume 137, Issue 4, Pages e6 (April 2016) DOI: /j.jaci Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Flow chart presenting the selection of study patients.
Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Cumulative incidence of asthma with and without comorbidities in the following 4 subgroups: M pneumoniae cohort with comorbidity, M pneumoniae cohort without comorbidity, non–M pneumoniae cohort with comorbidity, and non–M pneumoniae cohort without comorbidity. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig E1 Cumulative incidence of asthma in the M pneumoniae (dashed line) and non–M pneumoniae (solid line) cohorts. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig E2 Cumulative incidence of early-onset asthma in the M pneumoniae (dashed line) and non–M pneumoniae (solid line) cohorts. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig E3 Cumulative incidence of late-onset asthma in M pneumoniae (dashed line) and non–M pneumoniae (solid line) cohorts. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2015 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Incident asthma and Mycoplasma pneumoniae: A nationwide cohort study"

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
D-dimer: A biomarker for antihistamine-resistant chronic urticaria

D-dimer: A biomarker for antihistamine-resistant chronic urticaria
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,
Allergen immunotherapy: A practice parameter third update

Allergen immunotherapy: A practice parameter third update
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,

A cluster-randomized trial to provide clinicians inhaled corticosteroid adherence information for their patients with asthma  L. Keoki Williams, MD, MPH,
Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,

Information technology–based approaches to reducing repeat drug exposure in patients with known drug allergies  Kathrin M. Cresswell, MSc, Aziz Sheikh,
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Does atopic dermatitis cause food allergy? A systematic review

Does atopic dermatitis cause food allergy? A systematic review
Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 

Dorothy M. Ryan, MD, Stephen J. Fowler, MD, Robert M. Niven, MD 
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 

Similar presentations

Ads by Google